Product Detail
Misoprostol Acid (10 mg in 1 mL Methyl Acetate)
Misoprostol Metabolite
Stock Status: Enquire
Live
For Research & Analytical Purposes. Not for Personal use.
Category
Metabolite
API Family
Misoprostol
Storage
Refer MSDS for complete information.
Hazard Information
Refer MSDS for complete information.
Misoprostol Acid (10 mg in 1 mL Methyl Acetate) Product Information
Misoprostol Acid (10 mg in 1 mL Methyl Acetate) is listed under Metabolite. It is associated with Misoprostol and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-96109.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight, stock enquiry details and supporting documentation.
Technical Data
Product Name
Misoprostol Acid (10 mg in 1 mL Methyl Acetate)
CAS No.
112137-89-0
CAT No.
CS-T-96109
Molecular Formula
C21H36O5
Molecular Weight
368.51
Category
API Family
Storage Condition
Refer MSDS for complete information.
SMILES
OC(CCCCCC[C@@H]1[C@H]([C@@H](CC1=O)O)/C=C/CC(C)(O)CCCC)=O
IUPAC Name
7-((1R,2R,3R)-3-hydroxy-2-((E)-4-hydroxy-4-methyloct-1-en-1-yl)-5-oxocyclopentyl)heptanoic acid
Hazard Compound
Refer MSDS for complete information.
Description
Overview
A metabolite of Misoprostol. Cytoprotective PGE1 analog that prevents NSAID-induced gastric ulceration.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
Synonyms
7-((1R,2R,3R)-3-hydroxy-2-((E)-4-hydroxy-4-methyloct-1-en-1-yl)-5-oxocyclopentyl)heptanoic acid; (11α,13E)-11,16-Dihydroxy-16-methyl-9-oxo-prost-13-en-1-oic Acid; Misoprostol Free Acid; (+/-)-15-Deoxy-(16RS)-16-hydroxy-16-methylprogestaglandin E1
Application Notes
A metabolite of Misoprostol. Cytoprotective PGE1 analog that prevents NSAID-induced gastric ulceration.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References
Graham, Y., et al.: Lancet, 2, 1277 (1988), 11) Garris, R., et al.: Clin. Pharmacol., 8, 627 (1989), Karim, A., et al.: J. Clin. Pharmacol., 29, 439
